Detalhe da pesquisa
1.
A real-life study of daratumumab-bortezomib-dexamethasone (D-VD) in lenalidomide exposed/refractory multiple myeloma patients: a report from the Triveneto Myeloma Working Group.
Ann Hematol
; 103(1): 125-132, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37731147
2.
SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort.
Hematol Oncol
; 41(1): 128-138, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36265128
3.
Lack of efficacy of convalescent plasma in COVID-19 patients with concomitant hematological malignancies: An Italian retrospective study.
Hematol Oncol
; 40(5): 857-863, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35932208
4.
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV.
Hematol Oncol
; 40(5): 846-856, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35854643
5.
Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse.
Br J Haematol
; 188(6): 907-917, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31898319
6.
Prognostic value of PET/CT in patients with lymphoma treated with autologous stem cell transplantation for relapsed/refractory or high risk disease.
Q J Nucl Med Mol Imaging
; 63(1): 62-67, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26101430
7.
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi.
Biol Blood Marrow Transplant
; 24(9): 1814-1822, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29857196
8.
IDH2R172 mutation in angioimmunoblastic T-cell lymphoma: A retrospective multicenter case series.
Eur J Haematol
; 110(2): 217-220, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36264618
9.
Flai (fludarabine, cytarabine, idarubicin) plus low-dose Gemtuzumab Ozogamicin as induction therapy in CD33-positive AML: Final results and long term outcome of a phase II multicenter clinical trial.
Am J Hematol
; 93(5): 655-663, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29396857
10.
Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma.
Haematologica
; 102(11): 1931-1935, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28775121
11.
The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib.
Am J Hematol
; 92(8): 797-805, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28466557
12.
Multicentre survey to explore current survival of patients with acute myeloid leukaemia who failed induction chemotherapy.
Eur J Haematol
; 96(6): 586-92, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26186084
13.
Complex karyotype, older age, and reduced first-line dose intensity determine poor survival in core binding factor acute myeloid leukemia patients with long-term follow-up.
Am J Hematol
; 90(6): 515-23, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25753065
14.
A real-world retrospective-prospective analysis of efficacy and safety of combined ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma: The northern Italy experience.
Cancer Med
; 13(7): e7071, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38558233
15.
Two novel missense mutations in EPOR gene causes erythrocytosis in two unrelated patients.
Br J Haematol
; 180(6): 908-911, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27982410
16.
BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients.
Blood
; 118(12): 3419-25, 2011 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-21816830
17.
Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party.
Blood
; 117(21): 5591-9, 2011 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-21450900
18.
Acquired Isolated Factor VII Deficiency in Plasma Cell Dyscrasias: A Brief Presentation of Two Plasma-Cell-Leukemia-Related Cases and Review of Literature.
J Clin Med
; 12(18)2023 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37762778
19.
Improved efficiency of daratumumab treatment of multiple myeloma adopting the subcutaneous route: A micro-costing analysis in three Italian hematology centers.
Cancer Med
; 12(23): 21480-21489, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37942566
20.
Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia.
Am J Hematol
; 87(1): 22-5, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22086870